{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:59Z","timestamp":1792788539823,"version":"4.5.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Pfizer Inc"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"\n Objectives<\/jats:title>\n The objective of this study was to assess the antimicrobial resistance (AMR) landscape and the impact of COVID-19 on AMR in Egypt, Iraq, Jordan, and Lebanon, and to gather expert opinions on the barriers to the implementation of antimicrobial stewardship (AMS) initiatives in the region.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A cross-sectional questionnaire survey was used to assess the current AMR landscape, existing AMS initiatives, barriers to implementing AMS initiatives, and the impact of COVID-19 on AMR in the four countries.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The survey was completed by 204 physicians from Egypt (n = 82), Lebanon (n = 49), Iraq (n = 43), and Jordan (n = 30). Previous antibiotic use and previous bacterial colonization were perceived as the most common risk factors for an increase in AMR. According to the survey, multidrug-resistant (MDR) gram-negative bacteria were most common in lower respiratory tract infections, and\n Klebsiella pneumoniae<\/jats:italic>\n and\n Escherichia coli<\/jats:italic>\n were the most commonly identified gram-negative bacteria in hospital-acquired infections. Only 14.8% of pediatric physicians and 28.6% of adult physicians reported that target pathogen genotyping and phenotyping were done in hospitals, and the most commonly reported reasons for the lack of testing were technological and resource constraints. These constraints, coupled with the scarcity and high cost of newer antibiotics, have been identified as the most significant barriers to the successful management of MDR gram-negative bacterial infections in the region. It was reported that the spectrum of activity and safety of the antibiotic, the site of infection, the presence of comorbidities, and published guidelines and local antibiograms determined the choice of empirical antibiotic therapy for patients in the region. The four countries experienced a significant rise in AMR due to several factors during the COVID-19 pandemic, including an increase in hospital occupancy, a shift in priorities away from AMR surveillance, and changes in AMR epidemiology. Additionally, the large volumes of unnecessary and unsubstantiated antibiotic prescriptions during the COVID-19 pandemic has led to subsequent antibiotic shortages and significant increases in AMR in the region. Physicians also noted that the majority of COVID-19 patients were already on antibiotics before visiting the healthcare facility. MDR gram-negative bacteria were found in the majority of COVID-19 patients admitted to the intensive care unit. Despite the fact that various AMS initiatives have been implemented, they are not standardized across the region. Some of the main barriers to AMS implementation in the region are a lack of adequately trained AMS staff, lack of AMS knowledge and training among healthcare professionals, financial constraints, and the lack of AMR surveillance systems.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n These survey results provide valuable insights into the existing AMR and AMS landscape in the region, as well as the barriers that impede efficient AMS and AMR management. Based on these findings, the authors developed a call to action that suggests ways for each country in the region to address these challenges.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0288550","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T13:54:11Z","timestamp":1690466051000},"page":"e0288550","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion"],"prefix":"10.1371","volume":"18","author":[{"given":"Abdul Rahman","family":"Bizri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia Abd","family":"El-Fattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafez Mahmoud","family":"Bazaraa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-6232","authenticated-orcid":true,"given":"Jamal Wadi","family":"Al Ramahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4870-8879","authenticated-orcid":true,"given":"Madonna","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Abdulmahdi Nahi","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowan","family":"El Masry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihane","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Jamal Al","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abdel","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"pone.0288550.ref001","unstructured":"World Health Organization. Antimicrobial resistance: World Health Organization; 2021 [updated November 17 2021. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance#:\u223c:text=What%20is%20antimicrobial%20resistance%3F,spread%2C%20severe%20illness%20and%20death]."},{"key":"pone.0288550.ref002","unstructured":"World Health Organization. Global action plan on antimicrobial resistance. 2015 [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241509763]."},{"issue":"12","key":"pone.0288550.ref003","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions","volume":"13","author":"R Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"pone.0288550.ref004","first-page":"605","article-title":"Editorials: Antibiotic overuse: a key driver of antimicrobial resistance","author":"LJ Shallcross","year":"2014","journal-title":"Br J Gen Pract"},{"issue":"3","key":"pone.0288550.ref005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41564-018-0121-y","article-title":"Clinical challenges in antimicrobial resistance","volume":"3","author":"G. Barlow","year":"2018","journal-title":"Nat Microbiol"},{"key":"pone.0288550.ref006","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2217\/fmb-2018-0084","article-title":"Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice","volume":"13","author":"K Mitsakakis","year":"2018","journal-title":"Future Microbiol"},{"key":"pone.0288550.ref007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13756-017-0208-x","article-title":"The threat of antimicrobial resistance in developing countries: causes and control strategies","volume":"6","author":"JA Ayukekbong","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"issue":"10325","key":"pone.0288550.ref008","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"CJL Murray","year":"2022","journal-title":"The Lancet"},{"issue":"4","key":"pone.0288550.ref009","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/antibiotics10040393","article-title":"Antibiotic resistance in pediatric infections: global emerging threats, predicting the near future","volume":"10","author":"A Romandini","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"pone.0288550.ref010","doi-asserted-by":"crossref","first-page":"i939","DOI":"10.1136\/bmj.i939","article-title":"Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis","volume":"352","author":"A Bryce","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"pone.0288550.ref011","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8101626","article-title":"Retrospective analysis on antimicrobial resistance trends and prevalence of beta-lactamases in Escherichia coli and ESKAPE pathogens isolated from Arabian patients during 2000\u20132020","volume":"8","author":"M Nasser","year":"2020","journal-title":"Microorganisms"},{"key":"pone.0288550.ref012","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jgar.2021.08.005","article-title":"Phenotypic and genotypic characterisation of cephalosporin-, carbapenem- and colistin-resistant Gram-negative bacterial pathogens in Lebanon, Jordan and Iraq","volume":"27","author":"RA Moghnieh","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"e64139","key":"pone.0288550.ref013","article-title":"Antimicrobial resistance and COVID-19: intersections and implications","volume":"10","author":"GM Knight","year":"2021","journal-title":"Elife"},{"issue":"4","key":"pone.0288550.ref014","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"BJ Langford","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"pone.0288550.ref015","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/gheg.2017.4","article-title":"Antimicrobial resistance in human populations: challenges and opportunities","volume":"2","author":"S Allcock","year":"2017","journal-title":"Glob Health Epidemiol Genom"},{"issue":"2","key":"pone.0288550.ref016","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bcp.12417","article-title":"Antimicrobial stewardship\u2013can we afford to do without it","volume":"79","author":"A Aryee","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0288550.ref017","unstructured":"World Health Organization. Global framework for development and stewardship to combat antimicrobial resistance: draft roadmap. Geneva. 2017 [Available from: https:\/\/www.who.int\/publications\/m\/item\/global-framework-for-development-stewardship-to-combat-antimicrobial-resistance-draft-roadmap]."},{"key":"pone.0288550.ref018","first-page":"370","article-title":"Does antibiotic restriction prevent resistance?","volume":"4","author":"JE McGowan","year":"1996","journal-title":"New Horiz"},{"key":"pone.0288550.ref019","unstructured":"World Health Organization, Travis P, Egger D, Davies P, Mechbal A. Towards better stewardship: concepts and critical issues. Geneva. 2002 [Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/339291]."},{"key":"pone.0288550.ref020","unstructured":"World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit. 2019 [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241515481]."},{"key":"pone.0288550.ref021","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2017.07.017","article-title":"Antibiotic stewardship: does it work in hospital practice? A review of the evidence base","volume":"23","author":"MEJL Hulscher","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"pone.0288550.ref022","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1473-3099(18)30060-4","article-title":"WHO Global Antimicrobial Resistance Surveillance System early implementation 2016\u201317","volume":"18","author":"B Tornimbene","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"pone.0288550.ref023","unstructured":"World Health Organization. GLASS country participation. 2022 [Available from: https:\/\/www.who.int\/initiatives\/glass\/country-participation]."},{"issue":"11","key":"pone.0288550.ref024","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/antibiotics10111320","article-title":"Challenges to antimicrobial stewardship in the countries of the Arab League: concerns of worsening resistance during the COVID-19 pandemic and proposed solutions","volume":"10","author":"NA Rizk","year":"2021","journal-title":"Antibiotics"},{"issue":"6","key":"pone.0288550.ref025","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s40271-015-0141-0","article-title":"Ethics review of survey research: a mandatory requirement for publication?","volume":"8","author":"D Whicher","year":"2015","journal-title":"Patient"},{"issue":"1","key":"pone.0288550.ref026","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1186\/s12879-020-05503-8","article-title":"Antimicrobial resistance among GLASS pathogens in conflict and non-conflict affected settings in the Middle East: a systematic review","volume":"20","author":"C Truppa","year":"2020","journal-title":"BMC Infectious Diseases"},{"key":"pone.0288550.ref027","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2147\/IDR.S298920","article-title":"Landscape of multidrug-resistant gram-negative infections in Egypt: survey and literature review","volume":"14","author":"A El-Kholy","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"7","key":"pone.0288550.ref028","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jiph.2021.04.009","article-title":"Promoting cross-regional collaboration in antimicrobial stewardship: findings of an infectious diseases working group survey in Arab countries of the Middle East","volume":"14","author":"J Al Salman","year":"2021","journal-title":"J Infect Public Health"},{"issue":"6","key":"pone.0288550.ref029","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/antibiotics11060733","article-title":"Self-medication with antibiotics during COVID-19 in the Eastern Mediterranean region countries: a review","volume":"11","author":"F Jirjees","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"pone.0288550.ref030","unstructured":"World Health Organization. WHO policy guidance on integrated antimicrobial stewardship activities. 2021 [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240025530]."},{"key":"pone.0288550.ref031","unstructured":"World Health Organization. The WHO AWaRe (Access, Watch, Reserve) antibiotic book\u2014Infographics. 2022 [Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2022.02]."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T13:54:48Z","timestamp":1690466088000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0288550"}},"subtitle":[],"editor":[{"given":"Zhi","family":"Ruan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0288550","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}